Amicus Therapeutics (FOLD)
Create an AlertFOLD Key Stats
| Income Statement | |
| Revenue TTM | 10.64M |
| Revenue Quarterly YoY Growth | -100.0% |
| EPS Diluted TTM | -1.092 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -53.11M |
| Profitability | |
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | |
| Dividend | |
| Dividend Yield | 0% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 122.09M |
| Enterprise Value | 40.67M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 2.289 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.0112 |
| Free Cash Flow | -14.27M |
| Return on Equity | -75.17% |
FOLD News
- AMICUS THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of S... Jun 18
- Stocks Pare Gains on Speculation of Fed Tapering Jun 17
- Amicus Therapeutics' CEO Presents at Fabry Monotherapy Strategic Update Conferen... Jun 17
- Notable 52-Week Highs and Lows of the Day 06/17: (MU) (CSCO) (ALU) High; (WLT) (... Jun 17
- Unusual 11 Mid-Day Movers 06/17: (KNDI) (FRO) (LIVE) Higher; (FOLD) (ORMP) (SGOC... Jun 17
- Analysts: Yahoo Won’t Reach Google Deal and 3 More Research Notes to Explore Jun 17
- Amicus Falls as Fabry Disease Drug Trials Need More Time Jun 17
- Amicus falls to annual low on Fabry drug ruling Jun 17
- Tesla Rides a New Upgrade, BioScrip Buys CarePoint, and 3 More Hot Stocks Jun 17
- StreetInsider.com Pre-Open Movers 6/17: (KNDI) (NFLX) (AMD) Higher; (FOLD) (TEX)... Jun 17
FOLD Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Amicus Therapeutics is down 52.42% over the last year vs S&P 500 Total Return up 23.89%, Achillion Pharmaceuticals up 23.63%, and Insmed up 273.4%.
FOLD Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these FOLD related companies
Pro Ratings for FOLD
Pro Report PDF for FOLD
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download FOLD Pro Report PDF
Pro Strategies Featuring FOLD
Did Amicus Therapeutics make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
FOLD Profile
Sector: Healthcare
Industry: Biotechnology
Other FOLD Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| FOLD | 2.46 | -0.06 | -2.19% | 122.09M |
